How it works.
Semaglutide is a 31-residue GLP-1 analog modified at position 8 (Aib) to resist DPP-4 degradation and conjugated at K26 to a C18 fatty diacid linker that promotes albumin binding. Half-life is approximately 165 hours — roughly 100× that of native GLP-1. In binding studies it engages the GLP-1 receptor with sub-nanomolar affinity, producing downstream effects on insulin secretion, glucagon suppression, gastric emptying, and central satiety pathways.
Verified buyer notes.
Initials only — every quote is verified against an order record. We don’t ghost-write reviews.
“COA matched what we ran in-house. Powder reconstituted clean, no haze. Did exactly what we needed it to.”
“Switched after two bad lots from a previous source. Three orders in, zero issues.”
“Shipment got delayed two days by weather and still arrived at 4°C. Packaging is no joke.”
The shared signature.
04Coming soonA dual GIP/GLP-1 receptor agonist studied for its effects on glycemic regulation and adipose tissue metabolism.
04Coming soonA long-acting amylin analog studied as an adjunct to GLP-1 agonism in metabolic research.
04Coming soonA 16-amino-acid fragment of human growth hormone studied for its effects on lipolysis without GH receptor activity.